| Jul 9 2025
لوگو

Endocrinology and Metabolism Research Center

Tehran University of Medical Sciences

  • Release Date : Jun 28 2025 - 12:23
  • : 2
  • Study time : Less than one minute

thyroid cancer

Continued rise in the incidence of thyroid cancer in Iran: true increase or overdiagnosis

Thyroid cancer (TC) is commonly recognized as the most prevalent type of malignancy affecting the endocrine system. This study aimed to assess the incidence of TC and its trends in the Iranian population

 {faces}

From 2014 to 2018, a total of 27,530 cases of TC were recorded. Among these cases, 21,932 (79.7%) were female, and 5,598 (20.3%) were male. The age-standardized incidence rate (ASR) of TC was 6.17 (95% confidence interval [CI]: 6.09-6.25) per 100,000 person-years, showing an upward trend from 4.61 (95% CI: 4.45-4.77) per 100,000 population in 2014 to 8.17 (95% CI: 7.97-8.37) in 2018. The ASR of TC in women was nearly 3.7 times higher than that in men (9.79 vs. 2.59 per 100,000 person-years). The ASR of TC was highest in younger age groups among women (40-50 years) compared to men, who had higher rates in older age groups (65-75 years). Papillary thyroid carcinoma (PTC), including its follicular variant, was the predominant histological type of TC in the Iranian population, accounting for 82.19% (n = 22,627) of cases, followed by follicular thyroid carcinoma (FTC) (n = 859; 3.12%).

  • Article_DOI : 10.1007/s40200-025-01581-0
  • Author(s) : nooshin shirzad, bagher larijani,mahnaz pejman sani,mohammadreza mohajeri-tehrani
  • News Group : Research,Scientific articles,Research,Scientific articles
  • News Code : 300099
fatemeh zakerhoseini
Author:

fatemeh zakerhoseini

0 Comments for this article

comment

Post your comment:

متن درون تصویر را در جعبه متن زیر وارد نمائید *
Enter your desired term to search
Theme settings